TITAN PHARMACEUTICAL INC
TTNP Real Time Price USDRecent trades of TTNP by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by TTNP's directors and management
Government lobbying spending instances
-
$10,000 Jun 03, 2021 Issue: Health Issues
-
$10,000 Apr 20, 2021 Issue: None
-
$10,000 Jan 12, 2021 Issue: Health Issues
-
$20,000 Oct 19, 2020 Issue: Health Issues
-
$10,000 Oct 07, 2020 Issue: Health Issues
-
$20,000 Jul 13, 2020 Issue: Health Issues
-
$10,000 Jul 08, 2020 Issue: Health Issues
-
$10,000 Apr 20, 2020 Issue: Health Issues
-
$20,000 Apr 16, 2020 Issue: Health Issues
-
$20,000 Jan 17, 2020 Issue: Health Issues
-
$20,000 Oct 17, 2019 Issue: Health Issues
-
$20,000 Jul 19, 2019 Issue: Health Issues
-
$20,000 Apr 17, 2019 Issue: Health Issues
-
$10,000 Apr 14, 2019 Issue: Alcohol and Drug Abuse Health Issues
-
$10,000 Feb 22, 2019 Issue: None
-
$10,000 Jan 16, 2019 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Heterogeneous implantable devices for drug delivery Nov. 13, 2018
-
Patent Title: Heterogeneous implantable devices for drug delivery Oct. 30, 2018
-
Patent Title: Implantable polymeric device for sustained release of dopamine agonist Mar. 08, 2016
-
Patent Title: Implantable polymeric device for sustained release of dopamine agonist Oct. 07, 2014
-
Patent Title: Implantable polymeric device for sustained release of buprenorphine Jun. 15, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of TTNP in WallStreetBets Daily Discussion
Recent insights relating to TTNP
Recent picks made for TTNP stock on CNBC
ETFs with the largest estimated holdings in TTNP
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view TTNP Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.